Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.
Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 million people at risk. Due to the non availability of an ideal drug, development of a safe, effective, and affordable vaccine could be a solution for control and prevention of this disease. In this st...
Guardado en:
Autores principales: | Pramod K Kushawaha, Reema Gupta, Chandra Dev Pati Tripathi, Prashant Khare, Anil Kumar Jaiswal, Shyam Sundar, Anuradha Dube |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f425a77b9b44a21983cfdfd7bb199ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
por: Anil Kumar Jaiswal, et al.
Publicado: (2014) -
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
por: Albert Picado, et al.
Publicado: (2014) -
Over-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovani.
por: Sanchita Das, et al.
Publicado: (2013) -
Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms.
por: Tapan Bhattacharyya, et al.
Publicado: (2013) -
Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
por: Susanne U. Franssen, et al.
Publicado: (2021)